Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London
· Delayed Price · Currency is GBP · Price in USD 262.11
+2.19 (0.84%)
At close: May 12, 2025
Alnylam Pharmaceuticals Employees
Alnylam Pharmaceuticals had 2,230 employees as of December 31, 2024. The number of employees increased by 130 or 6.19% compared to the previous year.
Employees
2,230
Change (1Y)
130
Growth (1Y)
6.19%
Revenue / Employee
814.98K GBP
Profits / Employee
-93.61K GBP
Market Cap
26.67B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Alnylam Pharmaceuticals News
- 1 day ago - Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress - Business Wire
- 4 days ago - $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today - Benzinga
- 8 days ago - Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference - Business Wire
- 10 days ago - Alnylam Delivers Q1 Surprise, Analysts Highlight Amvuttra Momentum, Limited Tariff Risk - Benzinga
- 11 days ago - Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
- 12 days ago - Biogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff Impact - Benzinga
- 12 days ago - Alnylam Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 12 days ago - Alnylam reiterates 2025 guidance with projected 36% growth in TTR franchise revenues - Seeking Alpha